Study of REGN1193 in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT02284425 · TERMINATED
Trial details
- NCT number
- NCT02284425
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-12-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.